BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33936956)

  • 21. Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.
    Ela Bella AJ; Zhang YR; Fan W; Luo KJ; Rong TH; Lin P; Yang H; Fu JH
    Chin J Cancer; 2014 Apr; 33(4):211-7. PubMed ID: 24559853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of
    Fu L; Cheng A; Sun M; Wang X; Fu J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):517-522. PubMed ID: 29488719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.
    Nakayama M; Okizaki A; Ishitoya S; Sakaguchi M; Sato J; Aburano T
    Ann Nucl Med; 2013 Feb; 27(2):163-9. PubMed ID: 23188388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
    Yoo J; Kim BS; Chung J; Yoon HJ
    Medicine (Baltimore); 2017 Aug; 96(31):e7657. PubMed ID: 28767583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
    Matsubara R; Kawano S; Chikui T; Kiyosue T; Goto Y; Hirano M; Jinno T; Nagata T; Oobu K; Abe K; Nakamura S
    Acad Radiol; 2012 Jun; 19(6):708-17. PubMed ID: 22484437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT.
    Sasada S; Masumoto N; Kimura Y; Kajitani K; Emi A; Kadoya T; Okada M
    AJR Am J Roentgenol; 2019 Nov; 213(5):1129-1135. PubMed ID: 31339353
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of Dual-Timepoint
    Collarino A; Garganese G; Valdés Olmos RA; Stefanelli A; Perotti G; Mirk P; Fragomeni SM; Ieria FP; Scambia G; Giordano A; Rufini V
    J Nucl Med; 2017 Dec; 58(12):1913-1918. PubMed ID: 28546331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative prediction of the pathological stage of advanced gastric cancer by
    Yamada K; Urakawa N; Kanaji S; Hasegawa H; Yamamoto M; Yamashita K; Matsuda T; Oshikiri T; Suzuki S; Kakeji Y
    Sci Rep; 2022 Jul; 12(1):11370. PubMed ID: 35790785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting the accuracy of
    Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
    Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer.
    García Vicente AM; Soriano Castrejón A; Cruz Mora MÁ; Ortega Ruiperez C; Espinosa Aunión R; León Martín A; González Ageitos A; Van Gómez López O
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):1-5. PubMed ID: 23707190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.
    Calabria F; Bagnato A; Guadagnino G; Toteda M; Lanzillotta A; Cardei S; Tavolaro R; Leporace M
    Oncol Res; 2023; 31(2):117-124. PubMed ID: 37304242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ratio between maximum standardized uptake value of N1 lymph nodes and tumor predicts N2 disease in patients with non-small cell lung cancer in 18F-FDG PET-CT scan.
    Honguero Martínez AF; García Jiménez MD; García Vicente A; López-Torres Hidalgo J; Colon MJ; van Gómez López O; Soriano Castrejón ÁM; León Atance P
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):159-64. PubMed ID: 26514322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.
    Budiawan H; Cheon GJ; Im HJ; Lee SJ; Paeng JC; Kang KW; Chung JK; Lee DS
    Nucl Med Mol Imaging; 2013 Dec; 47(4):232-41. PubMed ID: 24900118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Value of
    Tatar G; Özkul Ö; Alçin G
    Mol Imaging Radionucl Ther; 2022 Jun; 31(2):123-129. PubMed ID: 35770978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtype-Guided
    Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
    Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative accuracy of qualitative and quantitative 18F-FDG PET/CT analysis in detection of lymph node metastasis from anal cancer.
    Chulroek T; Kordbacheh H; Wangcharoenrung D; Cattapan K; Heidari P; Harisinghani MG
    Abdom Radiol (NY); 2019 Mar; 44(3):828-835. PubMed ID: 30694369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Jul; 23(5):427-35. PubMed ID: 19437097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.